KRISTA PERRY: Open Payments
NPI 1720773807 · BOUNTIFUL, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 44 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $269 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $230 |
| Grifols USA, LLC | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $76 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Lundbeck LLC | 3 | $56 |
| Astellas Pharma US Inc | 2 | $41 |
| Krystal Biotech Inc | 1 | $31 |
| Lilly USA, LLC | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: VRAYLAR, QULIPTA, JARDIANCE, Prolastin-C Liquid, REXULTI, SHINGRIX, Veozah, BREZTRI.
Industry payments across UT — which companies pay providers there.
